A new rhesus macaque animal model recapitulates the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) observed in humans by mimicking natural infection via the nasal route, according to a study published November 12 in the open-access journal PLOS Pathogens by Longding Liu, Qihan Li, Zhanlong He of the Chinese Academy of Medical Sciences & Peking Union Medical College, and colleagues. As noted by the authors, the new animal model could lead to effective treatments or vaccines for COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The first step of all effective means to control COVID-19 and develop vaccines is to understand the viral infection process. Toward that goal, an effective animal model of SARS-CoV-2 infection is urgently needed. In the new study, the researchers developed a rhesus macaque model to mimic natural infection via the nasal route. The rhesus macaques displayed similar clinical and pathological manifestations of COVID-19 observed in humans.
The results revealed SARS-CoV-2 virus shedding- the release of virus progeny following successful reproduction — in the nose and stool for up to 27 days. This pattern of long-term viral shedding in rhesus macaques is strikingly similar to that observed in humans. The authors also observed similar pathological changes between humans and rhesus macaques in the progression from mild to marked interstitial pneumonia — an inflammatory condition affecting the tissue and space around the air sacs of the lungs. The results further revealed immune responses involving T cells, which contributed to the progression of COVID-19, and inflammation-promoting, cell-signaling molecules called inflammatory cytokines in the respiratory tract. The findings suggest that the development of COVID-19 treatments and vaccines should focus not only on viral shedding and interstitial pneumonia, but also T cell responses and cytokine changes in the lungs.
The authors conclude that their study of “nasal infection in rhesus monkey revealed the immune response and pathologic process of COVID-19.”
make a difference: sponsored opportunity
Materials provided by PLOS. Note: Content may be edited for style and length.
- Huiwen Zheng, Heng Li, Lei Guo, Yan Liang, Jing Li, Xi Wang, Yunguang Hu, Lichun Wang, Yun Liao, Fengmei Yang, Yanyan Li, Shengtao Fan, Dandan Li, Pingfang Cui, Qingling Wang, Haijing Shi, Yanli Chen, Zening Yang, Jinling Yang, Dong Shen, Wei Cun, Xiaofang Zhou, Xingqi Dong, Yunchuan Wang, Yong Chen, Qing Dai, Weihua Jin, Zhanlong He, Qihan Li, Longding Liu. Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression. PLOS Pathogens, 2020; 16 (11): e1008949 DOI: 10.1371/journal.ppat.1008949
Cite This Page:
PLOS. “Mimicking SARS-CoV-2 nasal infection in monkeys.” ScienceDaily. ScienceDaily, 12 November 2020. <www.sciencedaily.com/releases/2020/11/201112144020.htm>.
PLOS. (2020, November 12). Mimicking SARS-CoV-2 nasal infection in monkeys. ScienceDaily. Retrieved November 12, 2020 from www.sciencedaily.com/releases/2020/11/201112144020.htm
PLOS. “Mimicking SARS-CoV-2 nasal infection in monkeys.” ScienceDaily. www.sciencedaily.com/releases/2020/11/201112144020.htm (accessed November 12, 2020).